Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Loan Conversion

23 Dec 2005 07:00

Embargoed Release: 07:00hrs Friday 23rd December 2005 SOPHEON PLC Conversion of loan stock Extension of Equity Line Agreement International Financial Reporting Standards Change of Auditors Sopheon plc announces that it has issued 10,197,327 ordinary shares inconnection with the maturity of its remaining balance of ‚£1,223,679 ofconvertible loan stock. The convertible loan stock is now fully converted, asforeseen in Sopheon's annual report and other announcements. The conversion hasresulted in the issue of 3,250,000 ordinary shares to Mr B K Mence, a director,changing the total holding in which Mr Mence is beneficially interested to14,423,847 ordinary shares, representing 10.8% of the Company's issued sharecapital. The conversion has also resulted in the issue of 5,416,667 ordinaryshares to Norman Nominees Limited, changing its total shareholding to 9,891,260ordinary shares, representing 7.4% of the Company's issued share capital.Application has been made for the new ordinary shares, which are subject tocertain lock-in requirements, to be admitted to trading on AIM. Dealings areexpected to commence on 3 January 2006.Sopheon is also pleased to advise that its equity line of credit facility withGEM Global Yield Fund Limited ("GEM") due to expire today has been extended fora two year period through to 23 December 2007. As part of the agreement, thecosts of the extension, as well as outstanding commitment fees relating to theinitial term, have been satisfied by the issue of 400,000 ordinary shares toGEM at a price of 18p per ordinary share. Over 90% of the original ¢â€š¬10mfacility remains available under the extended agreeement. Application has beenmade for the new ordinary shares to be admitted to trading on AIM, and dealingsare expected to commence on 3 January 2006.Although Sopheon's AIM listing provides for an exemption from the adoption ofInternational Financial Reporting Standards ("IFRS") until the financialstatements for the year 2007, the board has continued to evaluate the relativemerits of early adoption of IFRS as opposed to continued application of UKGAAP. In view of the increasing importance of the group's shareholders thattrade through Euronext, coupled with the effect of extensive changes comingthrough in UK GAAP relating to its convergence with IFRS, the board has nowconcluded in consultation with its advisers that adoption of IFRS as of the2005 financial statements is appropriate.A detailed evaluation of the effects of the adoption of IFRS on Sopheon'sfinancial statements is ongoing but the preliminary conclusions as to the keyareas likely to be materially affected are (i) an option pricing model will beused to work out the fair value of share options granted during a period, withthis value being charged to the profit and loss account over the expectedvesting period; (ii) certain research and development expenditure may becapitalised and amortised based on detailed technical criteria, rather thanautomatically charging such costs in the profit and loss account as they arise;(iii) certain short term non-trade payables and receivables may requirerestatement or reclassification and (iv) certain acquired goodwill may requirereclassification as an intangible asset. It is not expected that the treatmentand reporting of Sopheon's revenues will be affected by the adoption of IFRS.Finally, the Sopheon board wishes to announce that BDO Stoy Hayward hasreplaced Ernst & Young as auditors with immediate effect. BDO is the world'sfifth largest accountancy network. Its focus on growth oriented companiesaligns well with Sopheon's business characteristics, and will deliver a morecost effective audit service. The BDO member firms in the Netherlands and inthe USA are respectively BDO CampsObers Accountants & Belastingadviseurs, andBDO Seidman LLP. Ernst & Young remain Sopheon's tax advisers.For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 ENDSOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.